Testing effectiveness (Phase 2)Study completedNCT02816476
What this trial is testing
Daratumumab Therapy for Patients With Refractory or Relapsed AL Amyloidosis
Who this might be right for
Amyloidosis
University Hospital, Limoges 40
Showing 20 of 0 results